We have completed maintenance on DiscoverMagazine.com and action may be required on your account. Learn More

The All-Purpose Tumor Remover

By Elizabeth Svoboda
Oct 25, 2012 5:00 AMNov 12, 2019 4:33 AM
Scanning electron microscopy image of a lymphocyte | Wikipedia


Sign up for our email newsletter for the latest science news

In March Stanford biomedical researcher Irving Weissman announced that he had discovered an antibody that disarms the survival mechanism of a wide variety of cancerous tumors.

Weissman’s research in mice had revealed that cancer cells produce large quantities of CD47, a protein that signals immune cells to spare the cancer cells. So he implanted various human tumors—including ovarian, breast, colon, liver, and brain—into mice and then injected the animals with antibodies that disable CD47. Robbed of their special protection, the tumors began to disappear almost immediately. Most of the breast tumors cleared completely.

Weissman plans to begin human clinical trials within a year. He envisions anti-CD47 drugs being used both as an adjunct to existing targeted cancer therapies and as a stand-alone treatment: “When you’ve finished surgery or radiotherapy and there’s very little tumor left, this antibody might work all by itself.”

1 free article left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

1 free articleSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!


Already a subscriber?

Register or Log In

More From Discover
Recommendations From Our Store
Shop Now
Stay Curious
Our List

Sign up for our weekly science updates.

To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2024 Kalmbach Media Co.